Betaxolol once-daily monotherapy for systemic hypertension: An open- label, uncontrolled trial

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 5, 1998, Pages 307-314

  Hwang, Yeo Shin ^a   Yen, Hsueh Wei ^a   Wu, Jung Chou ^a   Lin, Ching Cheng ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Ambulatory blood pressure monitoring; Betaxolol; Circadian rhythm; Monotherapy

Indexed keywords

BETAXOLOL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; FEMALE; HUMAN; HYPERTENSION; MALAISE; MALE; PRIORITY JOURNAL; SINUS BRADYCARDIA;

EID: 0031780379     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85070-4     Document Type: Article

References (18)

1. 1-Adrenoreceptor Antagonists. New York, NY: Raven Press; 1983:1-12.
2. Beresford R, Hell RL. Betaxolol: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension. Drugs. 1986;31:6-28.
3. 1-Adrenoreceptor Antagonists. New York, NY: Raven Press; 1983:51-64.
4. Garrett J, Fillingim J, Crouch T, Fernandes M. Effectiveness of 24-hour ambulatory blood pressure monitoring in establishing the use of antihypertensive compounds: An evaluation of betaxolol. 12th Scientific Meeting of The International Society of Hypertension; May 1988; Kyoto, Japan. Abstract 1138.
5. 1-Adrenoreceptor Antagonists. New York, NY: Raven Press; 1983:89-99.
6. Djian J. Clinical evaluation of betaxolol (Kerolone) as a once-daily treatment for hypertension in 4,685 patients. Br J Clin Pract. 1985;5:188-191.
7. Mroczek WJ, Burris JF, Hogan LB, et al. Comparison of the antihypertensive effects of betaxolol to atenolol. Am J Cardiol. 1988;16:807-811.
8. Harshfield GA, Pickering TG, Blank S, et al. Ambulatory blood pressure monitoring, records, application and analysis. In: Weber DA, Drager JM, eds. Ambulatory Blood Pressure Monitoring. New York, NY: Darmstadt Verlag; 1983:1-7.
9. Asmar R, Hugues CH, Pannier B, et al. Duration of action of bisoprolol after cessation of 4 week treatment and its influence on pulse wave velocity and aortic diameter: A pilot study in hypertensive patients. Eur Heart J. 1987;8(Suppl M):115-120.
10. DeQuattro V, Sirgo MA, Plachetka JR. Labetalol blunts morning pressure surge in systolic hypertension. Hypertension. 1988;11(Suppl I):I-198-I-201.
11. Sirgo MA, Mill SRJ, DeQuattro V. Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Arch Intern Med. 1988;148:2547-2552.
12. 1-Adrenoreceptor Antagonists. New York, NY: Raven Press; 1983:325-332.
13. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease and death: The NHANES I epidemiologic follow-up study. Am Heart J. 1991;121:172-177.
14. Thaulow E, Erikssen JE. How important is heart rate? J Hypertens. 1991;9(Suppl 17): 527-530.
15. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736-749.
16. Perski A, Olsson G, Landou C, et al. Minimum heart rate and coronary atherosclerosis: Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123:609-619.
17. Pickering TG, O'Brien E. Second international consensus meeting on twenty-four-hour ambulatory blood pressure measurement: Consensus and conclusion. J Hypertens. 1991;9(Suppl 8):S2-S5.
18. Mutti E, Trazi O, Omboni S, et al. Effect of placebo on 24-hour non-invasive ambulatory blood pressure. J Hypertens. 1991;9:361-364.